Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 85

Results For "brand"

1111 News Found

PhableCare raises Rs 187 crore in Series B funding
Startup | April 12, 2022

PhableCare raises Rs 187 crore in Series B funding

The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round


Dr. Morepen launches advanced muscle food
Healthcare | April 12, 2022

Dr. Morepen launches advanced muscle food

Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities


Aleor receives USFDA approval for Lidocaine and Prilocaine Cream
Drug Approval | April 12, 2022

Aleor receives USFDA approval for Lidocaine and Prilocaine Cream

Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre
News | April 10, 2022

AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre

With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country


CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
Biotech | April 08, 2022

CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India

Veeda Clinical Research will submit data in an application for Emergency Use Authorisation


Indian pharma growth likely to moderate in FY23: ICRA
News | April 07, 2022

Indian pharma growth likely to moderate in FY23: ICRA

Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23


Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Drug Approval | April 06, 2022

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19


Alvotech and STADA pave way to launching Hukyndra
Biotech | April 06, 2022

Alvotech and STADA pave way to launching Hukyndra

All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)